Department of Biochemistry, University of Zürich, Winterthurerstrasse 190, CH-8057 Zürich, Switzerland.
Department of Biochemistry, University of Zürich, Winterthurerstrasse 190, CH-8057 Zürich, Switzerland.
J Mol Biol. 2018 Jul 6;430(14):2128-2138. doi: 10.1016/j.jmb.2017.10.032. Epub 2017 Nov 8.
To untangle the complex signaling of the c-Jun N-terminal kinase (JNK) isoforms, we need tools that can selectively detect and inhibit individual isoforms. Because of the high similarity between JNK1, JNK2 and JNK3, it is very difficult to generate small-molecule inhibitors with this discriminatory power. Thus, we have recently selected protein binders from the designed ankyrin repeat protein (DARPin) library which were indeed isoform-specific inhibitors of JNK1 with low nanomolar potency. Here we provide the structural basis for their isotype discrimination and their inhibitory action. All our previous attempts to generate crystal structures of complexes had failed. We have now made use of a technology we recently developed which consists of rigid fusion of an additional special DARPin, which acts as a crystallization enhancer. This can be rigidly fused with different geometries, thereby generating a range of alternative crystal packings. The structures reveal the molecular basis for isoform specificity of the DARPins and their ability to prevent JNK activation and may thus form the basis of further investigation of the JNK family as well as novel approaches to drug design.
为了理清 c-Jun N 端激酶(JNK)同工型的复杂信号,我们需要能够选择性检测和抑制单个同工型的工具。由于 JNK1、JNK2 和 JNK3 之间具有高度的相似性,因此很难生成具有这种区分能力的小分子抑制剂。因此,我们最近从设计的锚蛋白重复蛋白(DARPin)文库中选择了蛋白质结合物,这些结合物实际上是 JNK1 的同工型特异性抑制剂,具有低纳摩尔效力。在这里,我们提供了它们同型区分和抑制作用的结构基础。我们之前所有生成复合物晶体结构的尝试都失败了。我们现在利用了我们最近开发的一项技术,该技术包括刚性融合一个额外的特殊 DARPin,它作为结晶增强剂。它可以以不同的几何形状刚性融合,从而产生一系列替代的晶体堆积。这些结构揭示了 DARPins 的同工型特异性的分子基础及其阻止 JNK 激活的能力,因此可能成为进一步研究 JNK 家族以及新型药物设计方法的基础。